Search the Newsreel

CareDx Number of Employees 2026 | Employee Count & Headcount Data

CareDx, Inc. (CDNA) had approximately 805 total employees worldwide as of March 2026, marking a 14.9% growth from 700 employees in 2023. The company is actively hiring, with 92 active job postings in 2026, though this represents a 28.0% decline from 2025. CareDx's workforce …

Class Action Lawsuit Filed Against GeneDx Holdings Corp. (WGS) - Recover Losses - Contact Levi & Korsinsky Before August 3, 2026

A class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ:WGS) by Levi & Korsinsky, LLP, on behalf of investors who purchased securities between April 16, 2025, and May 4, 2026. The lawsuit alleges that GeneDx Holdings Corp. made false and misleading statements …

Earnings call transcript: CareDx beats Q2 2026 estimates and lifts outlook

CareDx, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CDNA) 2026-07-30

CareDx, Inc. (CDNA) reported impressive Q2 2026 earnings, significantly beating EPS and revenue expectations. The company saw a 59.5% beat on EPS with $0.37 against an estimated $0.23, and revenue reached $132 million, surpassing the $114 million estimate by 15.7%. This strong performance was …

CareDx (NASDAQ: CDNA) swings to profit, sells lab products unit and buys Naveris

CareDx (CDNA) Beats Q2 Earnings and Revenue Estimates

MiMedx Group (NASDAQ:MDXG) Shares Gap Down on Disappointing Earnings

Levi & Korsinsky Reminds GeneDx Holdings Corp. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 3, 2026 - WGS

Levi & Korsinsky, LLP has issued a reminder to investors in GeneDx Holdings Corp. (NASDAQ: WGS) about a pending securities class action lawsuit. The lawsuit alleges that GeneDx management misled investors about deteriorating reimbursement rates and margin compression between April 16, 2025, and May …

MiMedx: Q2 Earnings Snapshot

This article provides a brief snapshot of MiMedx's Q2 earnings. No specific financial details or further information about the earnings are included in the provided content.

MiMedx Group to Acquire Sanara MedTech in Merger

MiMedx Group announced its agreement to acquire Sanara MedTech in a cash-and-stock merger, valuing Sanara at $35 per share, representing approximately $350 million in enterprise value and a 46% premium. This acquisition aims to nearly double MiMedx's surgical revenue, enhance profitability, and generate over …

Transcript : MiMedx Group, Inc., Q2 2026 Earnings Call, Jul 29, 2026

This article is a transcript of MiMedx Group, Inc.'s Q2 2026 Earnings Call, which took place on July 29, 2026. The content is primarily a message from the operator indicating the start of the conference call. The full transcript is reserved for subscribers.

Is MiMedx Group Inc (MDXG) Undervalued After Q2 Earnings Beat? E

MiMedx Group (Nasdaq: MDXG) posts Q2 loss, plans $350M Sanara acquisition

MiMedx Group reported sharply weaker Q2 2026 results with a net loss of $14.84 million, a significant drop from a prior-year profit, primarily due to a 61.1% decline in Wound revenue following Medicare reimbursement changes. Despite a 15.1% increase in Surgical revenue, overall net …

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MIMEDX (Nasdaq: MDXG) announced its second quarter 2026 operating and financial results, reporting net sales of $64 million, a 35% decrease year-over-year, largely due to Medicare reimbursement changes impacting its Wound business. Despite a strong 15% growth in its Surgical franchise, the company posted …

WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Faruqi & Faruqi, LLP is reminding investors of the August 3, 2026, deadline to seek lead plaintiff status in a federal securities class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS). The lawsuit alleges that GeneDx and its executives made misleading statements regarding the …

MIMEDX GROUP, INC. Q2 2026: Revenue $64.36M, EPS ($0.1) — 10-Q Summary

MIMEDX GROUP, INC. (MDXG) reported second-quarter 2026 results, showing a significant decline in revenue and a net loss, primarily due to Medicare reimbursement changes and reduced wound-product sales. Revenue fell to $64.36M from $98.61M year-over-year, leading to a diluted EPS of ($0.1). The company …

MiMedx Group (NASDAQ:MDXG) Releases Earnings Results, Meets Expectations

MiMedx earnings missed by $0.03, revenue topped estimates

MiMedx to buy Sanara MedTech (Nasdaq: SMTI) in $350 million cash-stock deal

BlackRock (NYSE: BLK) discloses 5.5% beneficial ownership in GeneDx (WGS)

BlackRock, Inc. has filed a Schedule 13G disclosing a 5.5% beneficial ownership in GeneDx Holdings Corp. (WGS). The filing indicates BlackRock owns 1,622,518 shares of Class A stock, with sole voting power over 1,588,670 shares and sole dispositive power over all 1,622,518 shares. No …

WGS 6-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS), urging investors with substantial losses to contact the firm before the August 3, 2026, lead plaintiff deadline. The lawsuit alleges GeneDx misled investors about the …

Portnoy Law Firm Announces Class Action on Behalf of GeneDX Holdings, Corp. Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in GeneDX Holdings, Corp. (NASDAQ: WGS). The lawsuit alleges that GeneDX made false and misleading statements to investors between April 16, 2025, and May 4, 2026, regarding its business, including …

GeneDx Holdings Corp. Class A Revenue Breakdown – BX:WGS

This article provides an overview of GeneDx Holdings Corp. Class A (BX:WGS) financial information available on TradingView, focusing on its revenue breakdown and segments. It highlights that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr. The content …

MONDAY DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead GeneDx Class Action Lawsuit - WGS

Investors in GeneDx Holdings Corp. (NASDAQ: WGS) who suffered losses between April 16, 2025, and May 4, 2026, have until August 3, 2026, to seek appointment as lead plaintiff in a class action lawsuit. The lawsuit alleges that GeneDx made misleading statements regarding the …

Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside

CDNA|CareDx Inc|Price:36.380|Chg%:-0.760

This article provides a detailed company profile for CareDx Inc (CDNA), a precision medicine solutions company specializing in healthcare solutions for transplant patients. It outlines their business scope, including various testing services and digital solutions, and provides key financial data, market performance metrics, and …

CareDx Inc (CDNA) Earnings Date & Reports & Earnings News

GENEDX HOLDINGS DEADLINE AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. has announced a class action lawsuit filed against GeneDx Holdings Corp. (NASDAQ:WGS) on behalf of investors who purchased common stock between April 16, 2025, and May 4, 2026. The lawsuit alleges that GeneDx and its executives made false and …

GeneDx Holdings Corp. (NASDAQ: WGS) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action

Robbins LLP has filed a securities class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of investors who purchased shares between April 16, 2025, and May 4, 2026. The lawsuit alleges that GeneDx misled investors about the financial benefits of its acquisition …

GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP has announced a securities fraud class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS). The lawsuit, filed on behalf of investors who purchased WGS common stock between April 16, 2025, and May 4, 2026, alleges that GeneDx made …

MiMedx Group Inc (MDXG) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of MiMedx Group Inc's (MDXG) stock performance, market capitalization, and P/E ratio. It specifically notes that the company has not distributed any dividends over the past five years. The page indicates financial and corporate information for MDXG available on …

CareDx Inc (CDNA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend history and stock splits for CareDx Inc (CDNA). It notes that the company has not distributed any dividends over the past five years. The page also presents current stock pricing, market capitalization, and links to various financial …

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against GeneDx Holdings Corp. (NASDAQ:WGS) and its officers, alleging violations of federal securities laws. The lawsuit claims that GeneDx made materially false and/or misleading statements regarding its business, operations, and prospects between April …

WGS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

NEW YORK, July 26, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important …

MiMedx Group Inc (MDXG) Cash Flow

This article provides a detailed cash flow statement for MiMedx Group Inc (MDXG), covering quarterly and annual data up to FY2026Q1. It breaks down various cash flow components including operating, investing, and financing activities, along with changes in working capital and specific asset transactions. …

WGS UPCOMING DEADLINE : The Gross Law Firm Alerts GeneDx Holdings Corp. Stockholders of Securities Class Action - Contact the Firm

The Gross Law Firm has issued a notice to shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) regarding a securities class action lawsuit. The lawsuit alleges that the company made false and misleading statements about the Fabric acquisition, leading to artificially inflated stock prices during …